Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
A triple-blind clinical trial investigated the therapeutic impact of a dodder and polypody herbal product (DPHP) in patients taking fluvoxamine [PMID:40848906].
In vivo and in vitro mouse models showed that P. vulgare extract was more effective than control/vehicle groups in new vascular, epidermal, and granulation tissue organization, with stronger PDGF, VEGF, and collagen staining [PMID:33717624].
Ethanolic extract was studied for cytotoxic effects on A375 melanoma cells [PMID:36708577].
Rhizome aqueous extract was found to enhance the activity of ciprofloxacin and photodynamic therapy (PDT) against uropathogenic E. coli [PMID:34959499].
Rhizomes were evaluated for in vitro cholinesterase inhibitory activity [PMID:28278615].
Synthèse des preuves
Sources PubMed
- 1.PMID: 21803067 (2011) — Ecdysteroids from Polypodium vulgare L. · Steroids
- 2.PMID: 31527294 (2019) — A review on the management of asthma in the Avicenna's Canon of Medicine. · Journal of complementary & integrative medicine
- 3.PMID: 31538499 (2021) — Isolation and structural determination of flavan-3-ol derivatives from the Polypodium vulgare L. rhizomes water extract. · Natural product research
- 4.PMID: 36708577 (2023) — Cytotoxic Effects of Ethanolic Extract of Polypodium Vulgare on Human Malignant Melanoma Cell Line. · Asian Pacific journal of cancer prevention : APJCP
- 5.PMID: 33717624 (2020) — An Alternative Approach Wound Healing Field with Polypodium Vulgare.